Cencora to buy American Oncology Network for $2.4 billion, expanding oncology services to 12 more states
Cencora Inc. signed a definitive agreement to acquire American Oncology Network (AON). The transaction values AON at an enterprise value of $2.4 billion, with $2.3 billion payable at closing and up to $100 million in contingent value rights. Cencora plans to increase its stake to 75% by paying roughly $1.7 billion, while allowing some AON shareholders to roll up to 25% of their equity. The deal is expected to lift Cencora’s adjusted diluted earnings per share in the second year after closing, pending regulatory and shareholder approvals.
Why it matters
Cencora says the purchase will raise its adjusted diluted EPS by the second year, which could improve profitability metrics for investors. The acquisition also adds AON’s physician‑led network in 21 states, giving Cencora a presence in twelve additional states and broadening its oncology management services platform.
Key facts
- 1The enterprise value of the transaction is $2.4 billion, consisting of $2.3 billion payable at closing and up to $100 million in contingent value rights. tradingview.com
- 2Cencora currently owns about 4% of AON and will acquire the remaining equity, aiming for a 75% stake after an equity rollover of up to 25% by certain AON shareholders. investing.com
- 3Cencora expects to pay approximately $1.7 billion to reach a 75% ownership level. investing.com
- 4The company projects the acquisition to be earnings‑per‑share accretive in the second year after closing. stocktitan.net
- 5Cencora updated its fiscal‑year‑2026 adjusted diluted EPS guidance to a minimum of $17.90, at the high end of the prior $17.75‑$17.95 range. investing.com
- 6The transaction adds AON’s network to Cencora’s platform, expanding its oncology services into twelve additional states. stocktitan.net
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.